Pharmaceutical

Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023

The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite various obstacles.

Mar 1, 2024 - 18:00
Market cap upturn for top 20 biopharma companies with obesity drug successes in 2023
The top 20 biopharmaceutical companies saw prominent shifts in market capitalisation over 2023 despite various obstacles.
Read the original article

Tags:

Previous Article

Green granulation: Tracking energy efficiency in pharmaceutical granulation

Next Article

FDA lifts two-year clinical hold on CytoDyn’s HIV trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Small and medium biotechs jump on obesity train

Small and medium biotechs jump on obesity train

Mar 31, 2023

STAT+: FTC’s Lina Khan makes a stop at Y Combinator, how telehealth helps rural America

STAT+: FTC’s Lina Khan makes a stop at Y Combinator, ho...

Nov 7, 2023

STAT+: 3 health policies states are taking on in 2024

STAT+: 3 health policies states are taking on in 2024

Dec 29, 2023